RecallRadar
ModerateReported November 11, 2026 (11 days ago)

TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC

Recalled by Victory Medical Center Pharmacy

Drug recall

Victory Medical Center Pharmacy

Class II — moderate

Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Victory Medical Center Pharmacy has recalled TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on November 11, 2026 and was initiated on October 19, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC, with approximately 208 vials affected. The company behind the recall is Victory Medical Center Pharmacy, based in Austin, TX. The FDA describes the product as: “TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas”

Why was TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC recalled?

According to the FDA, the stated reason for the recall is: “Lack of Processing Controls.”

What should you do?

If you think you may have bought TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC, compare it against the product description and identifying codes (Lot, expiry: Lot 2025319 , exp 10/23/2026; Lot 2064762 , exp 11/11/2026; Lot 2049664 , exp 11/19/2026) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Victory Medical Center Pharmacy or your local health authority.

About this recall

This recall was distributed in TX. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.

Who this recall affects

This recall matters to anyone who bought TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC. Even if you feel fine, it's worth checking what you have on hand rather than assuming you were missed.

Distribution listed in the notice: CO, FL, TX.

How to check whether you have it

On medicine bottles, the lot number and expiration date are printed on the pharmacy label or stamped directly on the manufacturer's bottle — often near the bottom edge or on the back. If a pharmacy label covers it, your pharmacist can look up the lot they dispensed.

Compare what you find against the identifying details in this recall: Lot, expiry: Lot 2025319 , exp 10/23/2026; Lot 2064762 , exp 11/11/2026; Lot 2049664 , exp 11/19/2026

What to do if you already bought it

Do not stop taking a prescribed medicine on your own because of a recall — for many conditions, an interrupted dose carries its own risk.

Instead, check the lot number against the details above and contact your pharmacist, who can confirm what they dispensed and arrange a replacement.

If you've had an unexpected reaction, contact your healthcare provider. Problems can also be reported to the FDA's MedWatch program.

Full recall details

Status
Ongoing
Date reported
November 11, 2026
Recall started
October 19, 2026
Distributed in
TX
What was recalled
TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
Why it was recalled (as stated by the FDA)
Lack of Processing Controls
How to identify the affected product
Lot, expiry: Lot 2025319 , exp 10/23/2026; Lot 2064762 , exp 11/11/2026; Lot 2049664 , exp 11/19/2026
Amount recalled
208 vials

What you can do

Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.

Quick answers

Why was TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC recalled?+

According to the FDA: Lack of Processing Controls

How serious is this recall?+

Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

What should I do if I have TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC?+

Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.

Share this recall:PostShareEmail
View the official FDA record →

Opens the U.S. Food and Drug Administration (FDA) data for this recall.

Recall number: D-0154-2027. Information last synced from the FDA on November 22, 2026.

Related recalls